Mrs. Diana Reche | Moduladores epigenéticos | Best Researcher Award

Mrs. Diana Reche , Universidad Pablo de Olavide , Spain

Diana Reche López is a dedicated Ph.D. student at the University of Pablo de Olavide, Spain, working within the Andalusian Center for Developmental Biology. Her research is centered around finding new treatments for KAT6B syndrome, a rare neurodegenerative disease. Diana holds a Bachelor’s in Biology from the University of Seville (2018) and a Master’s in Health Biotechnology from Universidad Pablo de Olavide (2020). She is a member of the PAIDI BIO-336 research group, where she specializes in cell culture techniques and experimental methodologies such as immunofluorescence and direct reprogramming. Diana has published numerous peer-reviewed articles and has gained significant recognition in her field, with 164 citations and an h-index of 7.

Publication Profile:

Scopus

Strengths for the Award:

1. Academic Background & Qualifications: Diana has a solid educational foundation, with a Bachelor’s degree in Biology and a Master’s in Health Biotechnology, both from reputable institutions in Spain (University of Seville and Universidad Pablo de Olavide). Her transition into a Ph.D. program shows a clear commitment to advancing her academic career.
2. Relevant Experience: Her research in rare neurodegenerative diseases, particularly focused on KAT6B syndrome and mitochondrial diseases, aligns with important gaps in medical science. She is involved in cutting-edge research concerning the mitochondrial unfolded protein response (mtUPR), offering promising therapeutic avenues for diseases with few treatment options.
3. Technical Expertise: Diana has hands-on experience with critical laboratory techniques, including cell culture, immunofluorescence, quantitative PCR, Western Blot, lentivirus production, and direct reprogramming. These skills are highly valued in biomedical research and allow her to contribute significantly to her projects.
4. Publication Record: Diana has co-authored multiple publications in well-respected journals, demonstrating her active involvement in high-level research. Her work is frequently cited (164 total citations, h-index of 7), reflecting the impact and relevance of her contributions. Her role in these publications, particularly her contributions to novel therapeutic approaches for rare diseases, showcases her potential as a future leader in her field.
5. Research Collaborations: Her work in various collaborative projects, particularly in the PI22/00142 project on mtUPR modulation, indicates her ability to work in multidisciplinary teams and contribute to complex research efforts. She also appears to be taking a leading role in novel areas, such as patient-derived cellular models for precision medicine.

Areas for Improvement:

1. Leadership and Independence: While Diana has demonstrated excellent collaborative skills, further developing her leadership capabilities could be beneficial. Taking a more active role in leading projects or research lines would solidify her position as an independent researcher.
2. Grant Funding and Project Leadership: Although she has been a participant in funded research projects, it would be advantageous for Diana to secure her own research grants or lead a research initiative. This would highlight her ability to drive research independently, an important factor for future academic success.
3. International Exposure: While Diana is based in Spain, participating in more international collaborations, conferences, or workshops could increase her visibility in the global scientific community. Networking and presenting her work at international platforms would further validate her contributions and expand her research opportunities.
4. Outreach and Public Engagement: Increasing her involvement in scientific outreach or public communication could enhance her impact. Sharing her findings with wider audiences could lead to greater public understanding of rare diseases and neurodegenerative conditions, helping to translate her research into real-world applications.

Education:

Diana Reche López earned a Bachelor’s degree in Biology from the University of Seville (2013–2018). She later pursued a Master’s in Health Biotechnology at the Universidad Pablo de Olavide (2018–2020), which laid the foundation for her current research work. As part of her doctoral research, Diana delves into the molecular mechanisms underlying rare neurodegenerative diseases, particularly KAT6B syndrome. She is currently continuing her Ph.D. studies at the University of Pablo de Olavide and is a key member of the PAIDI BIO-336 research group. Her academic background has equipped her with both theoretical and practical expertise in biotechnology, cellular biology, and disease modeling, making her a promising young researcher in the field of neurodegenerative diseases.

Experience:

Diana Reche López has gained extensive experience in cell biology and molecular techniques as part of her doctoral work at the Andalusian Center for Developmental Biology. Her research focuses on neurodegenerative diseases, specifically rare conditions like KAT6B syndrome. Throughout her career, she has developed expertise in cell culture, experimental protocols such as immunohistochemistry, quantitative PCR, Western Blotting, and direct cellular reprogramming. Diana has collaborated on various research projects funded by organizations such as the Instituto de Salud Carlos III. She has co-authored multiple peer-reviewed journal articles in leading scientific journals, contributing significantly to the understanding of mitochondrial dysfunction and therapeutic targets for rare diseases. She has also contributed to studies exploring mitochondrial unfolded protein responses (mtUPR) and their potential for treating mitochondrial diseases, publishing findings in well-regarded journals. Diana’s practical skills and dedication to research have made her a valuable member of her research group.

Research Focus:

Diana Reche López’s research focus is on exploring novel therapeutic approaches for rare neurodegenerative diseases, particularly KAT6B syndrome, a condition with no effective treatment other than palliative care. Her work revolves around understanding the molecular mechanisms of these diseases, with an emphasis on mitochondrial dysfunction and the mitochondrial unfolded protein response (mtUPR). She investigates how targeting mtUPR could offer potential therapies for mitochondrial diseases. Diana uses a variety of advanced experimental techniques, including cell culture, immunofluorescence, and direct reprogramming, to study the molecular pathology of these disorders. Her research also extends to examining the effects of supplements like pantothenate and L-carnitine on disease models, aiming to improve cellular health and therapeutic outcomes. Diana’s work contributes to the broader effort of developing targeted treatments for mitochondrial diseases, making her a promising researcher in the field of rare diseases and biotechnology.

Publications Top Notes:

1. Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels 🧬🧪
2. Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target? 💊🧠
3. UPRmt activation improves pathological alterations in cellular models of mitochondrial diseases 🧬🔬
4. Pantothenate and L-Carnitine Supplementation Improves Pathological Alterations in Cellular Models of KAT6A Syndrome 🔬💊
5. Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration ⚡🧠
6. mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases 🧬⚙️
7. Neurodegeneration, Mitochondria, and Antibiotics 🧪💡
8. Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration 🧬🧪
9. Antioxidants Prevent Iron Accumulation and Lipid Peroxidation, but Do Not Correct Autophagy Dysfunction or Mitochondrial Bioenergetics 🧪🧬
10. Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration 🧬🔬

Conclusion:

Diana Reche López is highly deserving of recognition for her research in the field of rare and neurodegenerative diseases. Her technical expertise, impressive publication record, and active role in impactful research projects make her a strong contender for the Research for Best Researcher Award.

While there are areas for improvement, particularly in gaining leadership experience and securing independent funding, her current trajectory as a researcher suggests that she is well on her way to making significant contributions to the scientific community. Her continued involvement in innovative research, combined with the potential for growth in leadership and international collaboration, makes her an excellent candidate for the award.